Immunology
-
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
This article has 6 authors:Reviewed by ScreenIT
-
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
This article has 17 authors:Reviewed by ScreenIT
-
Infection and transmission of SARS‐CoV‐2 depend on heparan sulfate proteoglycans
This article has 15 authors:Reviewed by ScreenIT
-
Single-cell sequencing of plasma cells from COVID-19 patients reveals highly expanded clonal lineages produce specific and neutralizing antibodies to SARS-CoV-2
This article has 18 authors:Reviewed by ScreenIT
-
Quantatitive Analysis of Conserved Sites on the SARS-CoV-2 Receptor-Binding Domain to Promote Development of Universal SARS-Like Coronavirus Vaccines
This article has 20 authors:Reviewed by ScreenIT
-
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
This article has 49 authors:Reviewed by ScreenIT
-
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
This article has 20 authors:Reviewed by ScreenIT
-
Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence
This article has 14 authors:Reviewed by ScreenIT
-
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis
This article has 50 authors:Reviewed by ScreenIT
-
A measles-vectored COVID-19 vaccine induces long-term immunity and protection from SARS-CoV-2 challenge in mice
This article has 16 authors:Reviewed by ScreenIT